MétaCan
Menu
← Back to cohort
Record W7117316379 · doi:10.1002/alz70858_100805

Understanding the clinical care pathway of patients with mild cognitive impairment due to Alzheimer's disease and dementia due to Alzheimer's disease: Results from a global real‐world survey

2025· article· en· W7117316379 on OpenAlexaboutno aff
Sharon Cohen, Sarah Cotton, Juan M. Fortea, Hisatomo Kowa, Nachiappan KR, Luis R Solís Tarazona, Chloe J. Walker

Bibliographic record

VenueAlzheimer s & Dementia · 2025
Typearticle
Languageen
FieldMedicine
TopicDementia and Cognitive Impairment Research
Canadian institutionsnot available
Fundersnot available
KeywordsDementiaCognitive impairmentDiseaseCognitionMEDLINEAlzheimer's diseaseClinical pathway

Abstract

fetched live from OpenAlex

BACKGROUND: With the emergence of disease modifying treatments, the importance of early diagnosis of mild cognitive impairment (MCI) and mild dementia due to Alzheimer's disease (AD) has increased. This research explores the global clinical care pathway with the aim of highlighting areas for improvement for early and accurate diagnosis. METHOD: Data were drawn from the Adelphi Real World AD Disease Specific Programme™, a cross-sectional survey of physicians and their patients in Canada, France, Germany, Italy, Spain, the United Kingdom, Japan, and the United States between December 2022 - March 2024. Physicians reported data on patient's diagnostic pathway, Mini-Mental State Examination (MMSE) score at first consultation, and treatment for approximately their next nine consulting patients diagnosed with MCI due to AD or dementia due to AD (clinically diagnosed or biomarker confirmed). Patients self-reported their reasons for delaying consultation. Data was grouped by MMSE. Analyses were descriptive. RESULT: Overall, 829 physicians reported data for 5654 patients; 726 self-completed forms. Patient mean (standard deviation) age was 76.7 (8.4) years and 48.0% were male. Of those with an MMSE score at first consultation, 20.6% had 26-30, 47.2% 21-25, 29.9% 11-20, and 2.3% 0-10. Time from symptom onset to first consultation was a median [interquartile range] of 20.7 [4.6, 52.0] weeks. Patients reported delaying first visiting a physician (75.1%), mainly due to believing their memory problems were a part of normal ageing (72.3%). Most patients first consulted a primary care physician (73.4% of patients with an MMSE of 26-30; 58.7% 0-10), of which 72.4% and 45.5%, respectively, were referred on for diagnosis. Key diagnostic tools were behavioural/cognitive assessments (91.8%), feedback from patient/patient's family (89.3%), and non-AD specific blood tests (88.7%). Biomarker testing was infrequent (11.8%). When treatment was prescribed, lack of efficacy was the key driver for change in initial treatment (48.9%). CONCLUSION: Our results highlight a lack of awareness of early symptoms, inconsistent referral, and infrequent utilization of AD specific biomarkers. Addressing these challenges is pivotal to facilitate early, accurate diagnosis and intervention. Lack of efficacy was the main reason for changing initial treatment, indicating the need for better treatment options.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.002
metaresearch head score (Gemma)0.008
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.046
Threshold uncertainty score0.091

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0020.008
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0010.002
Science and technology studies0.0000.000
Scholarly communication0.0010.001
Open science0.0000.001
Research integrity0.0010.000
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.069
GPT teacher head0.352
Teacher spread0.283 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueAlzheimer s & Dementia→Same topicDementia and Cognitive Impairment Research→French-language works237,207→